Lenalidomide as maintenance treatment for patients with multiple myeloma after autologous stem cell transplantation: A pharmaco‐economic assessment

OBJECTIVE: Autologous stem cell transplantation (ASCT) has improved progression‐free survival (PFS) and overall survival in eligible patients with newly diagnosed multiple myeloma (NDMM); however, relapse occurs. Maintenance therapy with lenalidomide (Len‐Mt) extends survival and delays relapse and...

Descripción completa

Detalles Bibliográficos
Autores principales: Uyl‐de Groot, Carin A., Ramsden, Rachel, Lee, Dawn, Boersma, Janneke, Zweegman, Sonja, Dhanasiri, Sujith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590122/
https://www.ncbi.nlm.nih.gov/pubmed/32705720
http://dx.doi.org/10.1111/ejh.13497

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590122/
https://www.ncbi.nlm.nih.gov/pubmed/32705720
http://dx.doi.org/10.1111/ejh.13497

Ejemplares similares